enVVeno Medical Corp (NVNO) stock
NVNONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$5.77+0.00 (0.00%)
Close on Nov 18, 2026Market cap $4.01MP/E –Yield –
enVVeno Medical cash
Cash and short-term investments held at the end of each period.
enVVeno Medical's cash was $18.47M at Sep 30, 2026. For fiscal 2025 it was $28.21M, down 34.6% from the year before. The highest annual figure on record is $54.73M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.21M | -34.6% |
| FY2024 | Dec 31, 2024 | $43.15M | -7.0% |
| FY2023 | Dec 31, 2023 | $46.41M | +18.9% |
| FY2022 | Dec 31, 2022 | $39.04M | -28.7% |
| FY2021 | Dec 31, 2021 | $54.73M | +486.3% |
| FY2020 | Dec 31, 2020 | $9.33M | +614.1% |
| FY2019 | Dec 31, 2019 | $1.31M | -52.3% |
| FY2018 | Dec 31, 2018 | $2.74M | +3427.8% |
| FY2017 | Dec 31, 2017 | $77.69K | +37.5% |
| FY2016 | Dec 31, 2016 | $56.51K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $18.47M | -40.3% |
| Q2 FY2026 | Jun 30, 2026 | $21.49M | -38.9% |
| Q1 FY2026 | Mar 31, 2026 | $24.93M | -36.0% |
| Q4 FY2025 | Dec 31, 2025 | $28.21M | -34.6% |
| Q3 FY2025 | Sep 30, 2025 | $30.95M | -36.0% |
| Q2 FY2025 | Jun 30, 2025 | $35.14M | -10.0% |
| Q1 FY2025 | Mar 31, 2025 | $38.94M | -9.3% |
| Q4 FY2024 | Dec 31, 2024 | $43.15M | -7.0% |
| Q3 FY2024 | Sep 30, 2024 | $48.38M | +88.3% |
| Q2 FY2024 | Jun 30, 2024 | $39.07M | +31.3% |
| Q1 FY2024 | Mar 31, 2024 | $42.94M | +25.5% |
| Q4 FY2023 | Dec 31, 2023 | $46.41M | +18.9% |
| Q3 FY2023 | Sep 30, 2023 | $25.70M | -36.3% |
| Q2 FY2023 | Jun 30, 2023 | $29.76M | -20.6% |
| Q1 FY2023 | Mar 31, 2023 | $34.21M | -33.4% |
| Q4 FY2022 | Dec 31, 2022 | $39.04M | -28.7% |
| Q3 FY2022 | Sep 30, 2022 | $40.33M | -30.3% |
| Q2 FY2022 | Jun 30, 2022 | $37.48M | -8.7% |
| Q1 FY2022 | Mar 31, 2022 | $51.34M | +17.1% |
| Q4 FY2021 | Dec 31, 2021 | $54.73M | +486.3% |
| Q3 FY2021 | Sep 30, 2021 | $57.90M | +928.5% |
| Q2 FY2021 | Jun 30, 2021 | $41.04M | +2524.1% |
| Q1 FY2021 | Mar 31, 2021 | $43.84M | +5987.3% |
| Q4 FY2020 | Dec 31, 2020 | $9.33M | +614.1% |
| Q3 FY2020 | Sep 30, 2020 | $5.63M | +91.2% |
| Q2 FY2020 | Jun 30, 2020 | $1.56M | -65.0% |
| Q1 FY2020 | Mar 31, 2020 | $720.13K | -73.8% |
| Q4 FY2019 | Dec 31, 2019 | $1.31M | -52.3% |
| Q3 FY2019 | Sep 30, 2019 | $2.94M | -29.7% |
| Q2 FY2019 | Jun 30, 2019 | $4.47M | -24.9% |
| Q1 FY2019 | Mar 31, 2019 | $2.75M | +790.4% |
| Q4 FY2018 | Dec 31, 2018 | $2.74M | +3427.8% |
| Q3 FY2018 | Sep 30, 2018 | $4.19M | +1245.0% |
| Q2 FY2018 | Jun 30, 2018 | $5.94M | +37236.2% |
| Q1 FY2018 | Mar 31, 2018 | $309.13K | +447.0% |
| Q4 FY2017 | Dec 31, 2017 | $77.69K | – |
| Q3 FY2017 | Sep 30, 2017 | $311.48K | – |
| Q2 FY2017 | Jun 30, 2017 | $15.92K | – |
| Q4 FY2016 | Dec 31, 2016 | $56.51K | – |
See a number that looks wrong?